New Maternal Vaccine in Development to Counter Antibiotic Overuse

The UK Health Security Agency (HSA) has announced it is developing a new maternal vaccine at its Porton Down laboratory in Wiltshire, which it claims could help fight the problem of antimicrobial resistance. Work is ongoing at the agency’s Vaccine Development Evaluation Centre at the high containment lab to create a pregnancy jab for Group B Streptococcus (GBS) because the government says antibiotic resistance is growing, putting infants at risk from the infection. The Bill and Melinda Gates Foundation has given money to fund the development of the proposed vaccine, the HSA said in its press release in late May....